Gyeonggi-do, South Korea

Woo Heon Song

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.2

ph-index = 1


Company Filing History:


Years Active: 2020-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Woo Heon Song

Introduction

Woo Heon Song is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 3 patents to his name, his work has the potential to impact various medical treatments.

Latest Patents

One of his latest patents is focused on rebamipide prodrugs. This patent discloses a novel rebamipide prodrug, a method for preparing it, and its use in medical applications. The rebamipide prodrug boasts a 25-fold increase in absorption rate compared to rebamipide itself. It can be applied to the prophylaxis or therapy of conditions such as gastric ulcers, acute gastritis, chronic gastritis, xerophthalmia, cancer, osteoarthritis, rheumatoid arthritis, and obesity. Another significant patent involves a pregabalin-containing, high swellable, sustained-release triple layer tablet. This tablet is designed for once-daily administration, enhancing patient compliance and treatment efficacy.

Career Highlights

Throughout his career, Woo Heon Song has worked with reputable companies in the pharmaceutical industry. Notable among these are Gl Pharmtech Corp. and Samjin Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise and innovative capabilities in drug development.

Collaborations

Woo Heon Song has collaborated with talented individuals in his field, including Kyung Hun Kim and Kyung Soo Lee. These collaborations have likely fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Woo Heon Song's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to improving medical treatments. His work has the potential to significantly enhance patient care and outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…